يعرض 1,061 - 1,080 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant ((we decrease) OR (teer decrease)) ))', وقت الاستعلام: 0.43s تنقيح النتائج
  1. 1061

    Flow chart. حسب Myriam Aïche (22290591)

    منشور في 2025
    الموضوعات:
  2. 1062
  3. 1063
  4. 1064
  5. 1065
  6. 1066

    Linear regression. حسب Myriam Aïche (22290591)

    منشور في 2025
    الموضوعات:
  7. 1067
  8. 1068
  9. 1069
  10. 1070
  11. 1071
  12. 1072
  13. 1073

    Flowchart of the study protocol. حسب Min Wang (21070)

    منشور في 2024
    الموضوعات:
  14. 1074
  15. 1075

    Subject characteristics (n = 45). حسب Min Wang (21070)

    منشور في 2024
    الموضوعات:
  16. 1076
  17. 1077
  18. 1078

    DataSheet1_The OsGAPC3 mutation significantly affects grain quality traits and improves the nutritional quality of rice.docx حسب Bo Peng (273834)

    منشور في 2024
    "…The number and volume of type-II protein bodies in the endosperm of the OsGAPC3 mutants, and GPC increase significantly. We report significant increases in chalkiness area and degree, and decreases for starch content, gel consistency, and taste value. …"
  19. 1079

    Data Sheet 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.pdf حسب Nourhen Agrebi (14151222)

    منشور في 2025
    "…</p>Objective<p>This study aims to elucidate the clinical implications of concurrent AICDA and IKBKB homozygous variants in a pediatric patient diagnosed with hyper-IgM syndrome.</p>Methods<p>We present immunological and genetic analysis of a Tunisian patient with two homozygous variants of uncertain significance (VUSs) in the IKBKB and AICDA genes, suspected of causing hyper-IgM and immune deficiency. …"
  20. 1080

    Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx حسب David Qixiang Chen (8198265)

    منشور في 2025
    "…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …"